Pacific Biosciences Of California (PACB) Revenue (2010 - 2026)

Pacific Biosciences Of California's Revenue history runs 17 years deep, the most recent figure standing at $37.2 million for Q1 2026.

• In Q1 2026, Revenue changed 0.07% year-over-year to $37.2 million; the TTM figure through Mar 2026 stood at $160.0 million (up 5.04% YoY), while the FY2025 annual figure was $160.0 million, up 3.89% from the prior year.
• Revenue was $37.2 million for Q1 2026 at Pacific Biosciences Of California, down from $44.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $58.4 million in Q4 2023 to a low of $27.4 million in Q4 2022.
• Historically, Revenue has averaged $40.0 million across 5 years, with a median of $38.8 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Revenue soared 113.35% in 2023, then tumbled 32.79% in 2024.
• A 5-year view of Revenue shows it stood at $27.4 million in 2022, then surged by 113.35% to $58.4 million in 2023, then sank by 32.79% to $39.2 million in 2024, then rose by 13.82% to $44.6 million in 2025, then dropped by 16.73% to $37.2 million in 2026.
• The last three Revenue figures came in at $37.2 million (Q1 2026), $44.6 million (Q4 2025), and $38.4 million (Q3 2025), per Business Quant data.